Vesper Healthcare Acquisition Corp.
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $460.00M |
|---|---|
| IPO Date | Sep 30, 2020 |
| CEO | Brenton L. Saunders |
| Left Lead | Goldman Sachs |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Pharmaceuticals and healthcare |
| IPO Geography | Global |
| Target Company | HydraFacial |
| Deal Announced | Dec 9, 2020 |
| Deal Size, $M | $1,140.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Apr 29, 2021 |
| Amendment Vote | TBD |
| Closing Date | May 5, 2021 |
Formerly VSPR
SKIN
SKINW
| Price | $1.48 |
|---|---|
| Last closing price | $1.62 |
| H/L, today | $1.48 / $1.60 |
| H/L, 52-week | $3.90 / $13.90 |
| Volume, today | 324,096 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Vesper Healthcare Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 19 filings and events
- 2 underwriters
- 4 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Brenton L. Saunders | 50 | President, CEO and Chairman |
| Dr. Manisha Narasimhan | 44 | CFO and Director |
| Michael D. Capellas | 66 | Director |
| Dr. Julius Few | 53 | Director |
| Barry S. Sternlicht | 59 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Goldman Sachs | Joint BR | 24,000,000 | units |
| JP Morgan | Joint BR | 16,000,000 | |
| 40,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.